
27 Aug 2015
Interims highlight manufacturing expansion progressing
OXB’s interim results highlight the continued efforts in expanding its manufacturing capacity with its existing facility operating at full capacity in H1 2015. The development pipeline continues to progress with additional trials anticipated to commence in 2016. We will update our forecasts in due course although note that H1 results indicate that a significant pick up is required in H2 to meet our estimates. 2015 has previously been flagged as the year the group would undertake a substantial ca ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Interims highlight manufacturing expansion progressing
Oxford BioMedica plc (OXB:LON) | 586 41 1.2% | Mkt Cap: 704.3m
- Published:
27 Aug 2015 -
Author:
Singer CM Team -
Pages:
4 -
OXB’s interim results highlight the continued efforts in expanding its manufacturing capacity with its existing facility operating at full capacity in H1 2015. The development pipeline continues to progress with additional trials anticipated to commence in 2016. We will update our forecasts in due course although note that H1 results indicate that a significant pick up is required in H2 to meet our estimates. 2015 has previously been flagged as the year the group would undertake a substantial ca ....